We use cookies and similar tools to give you the best website experience. By using our site, you accept our Websites Privacy Policy.
Genetic targets for inflammatory disease are the focus of new NIH-funded research.
The studies’ span speaks to NYU Langone’s strong ability to lead multicenter trials in rheumatology.
Studies show immunosuppressants do not significantly alter risk for worse COVID-19 outcomes.
Rheumatology Highlights 2019–2020
Studies explore rheumatoid arthritis medication responses and how psoriatic arthritis develops.
Explore the Issue
We can help you find a doctor. Call 646-929-7800 or browse our specialists.
